"What's the current value of a TAUG VTGN warrant?
Not a Story about what it could be, what is the current value?"
Good question.
"And to be clear, I'm certain TAUG has lost money on its VTGN investment, based on the current VTGN share price."
The company agrees:
"On December 11, 2017 the Company invested $480,000 in the common stock of VistaGen Therapeutics, Inc. (“VTGN”). The Company purchased 320,000 common shares along with 320,000 five-year warrants with a strike price of $1.50."
The Company’s investment in VTGN had a fair value of $356,288 at December 31, 2017.
The 10-Q does not provide that fair value calculation. I suspect that the warrants are valued at zero, as they should be.
But can it core A apple?
Yes Ralph, of course it can core A apple.
